ARTICLE | Clinical News
Atrigel leuprolide: Phase III
January 24, 2000 8:00 AM UTC
ATRX said that data from 36 patients who received multiple injections of Atrigel in an ongoing Phase III study showed that the product was safe and well tolerated, and reduced testosterone levels to l...